CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice
Abstract Background The imbalance of glutamate (Glu) and gamma-aminobutyric acid (GABA) neurotransmitter system plays a crucial role in the pathogenesis of Alzheimer’s disease (AD). Riluzole is a Glu modulator originally approved for amyotrophic lateral sclerosis that has shown potential neuroprotec...
Saved in:
Main Authors: | Yuanyu Shen, Xiaolei Zhang, Siqi Liu, Lijing Xin, Wentao Xuan, Caiyu Zhuang, Yue Chen, Beibei Chen, Xinhui Zheng, Renhua Wu, Yan Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-025-01672-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mapping hippocampal glutamate in healthy aging with in vivo glutamate-weighted CEST (GluCEST) imaging
by: Maggie K. Pecsok, et al.
Published: (2025-01-01) -
Modulation of brain glutamate dehydrogenase as a tool for controlling seizures
by: Rasgado Lourdes A. Vega, et al.
Published: (2015-12-01) -
Brain lesion MRI and co-related MRS spectroscopy datasetMendeley Data
by: Sura Riyadh Saleh, et al.
Published: (2025-04-01) -
Investigating Neurometabolite Changes in Response to Median Nerve Stimulation
by: Mairi S. Houlgreave, et al.
Published: (2025-01-01) -
Magnetic Resonance Spectroscopy (MRS) transforming multiple sclerosis (MS) diagnosis
by: Landoline Bonnin, et al.
Published: (2025-03-01)